1. 2020
  2. Adner, M., Canning, B. J., Meurs, H., Ford, W., Ramos Ramírez, P., van den Berg, M. P. M., Birrell, M. A., Stoffels, E., Lundblad, L. K. A., Nilsson, G. P., Olsson, H. K., Belvisi, M. G., & Dahlén, S-E. (2020). Back to the future: re-establishing guinea pig in vivo asthma models. Clinical Science, 134(11), 1219-1242. https://doi.org/10.1042/CS20200394
  3. Wójcik-Pszczoła, K., Chłoń-Rzepa, G., Jankowska, A., Ślusarczyk, M., Ferdek, P. E., Kusiak, A. A., Świerczek, A., Pociecha, K., Koczurkiewicz-Adamczyk, P., Wyska, E., Pękala, E., & Gosens, R. (2020). A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling. International Journal of Molecular Sciences, 21(11), [4008]. https://doi.org/10.3390/ijms21114008
  4. Meurs, H., Zaagsma, J., Maarsingh, H., & van Duin, M. (2020). Reply to: Arginase inhibitors. Allergy, 75(6), 1527-1528. https://doi.org/10.1111/all.14211
  5. Krabbendam, I. E., Honrath, B., Dilberger, B., Iannetti, E. F., Branicky, R. S., Meyer, T., Evers, B., Dekker, F. J., Koopman, W. J. H., Beyrath, J., Bano, D., Schmidt, M., Bakker, B. M., Hekimi, S., Culmsee, C., Eckert, G. P., & Dolga, A. M. (2020). SK channel-mediated metabolic escape to glycolysis inhibits ferroptosis and supports stress resistance in C. elegans. Cell death & disease, 11(4), [263]. https://doi.org/10.1038/s41419-020-2458-4
  6. de Winter, J. M., van den Berg, M. P., Strohm, J., Jongbloed, J. D., van der Roest, W., van Wijngaarden, J., Timmermans, J., Kamsteeg, E. J., van Engelen, B. G., van der Pijl, R. J., Granzier, H., Voermans, N. C., van Spaendonck-Zwarts, K., & Ottenheijm, C. A. C. (2020). KBTBD13: a novel gene implicated in cardiomyopathy. Journal of molecular and cellular cardiology, 140, 6. https://doi.org/10.1016/j.yjmcc.2018.05.031
  7. Folkerts, J., Redegeld, F., Folkerts, G., Blokhuis, B., van den Berg, M. P. M., de Bruijn, M. J. W., van IJcken, W. F. J., Junt, T., Tam, S-Y., Galli, S. J., Hendriks, R. W., Stadhouders, R., & Maurer, M. (2020). Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI-mediated signaling. Allergy. https://doi.org/10.1111/all.14254
  8. Gosens, R., Hiemstra, P. S., Adcock, I. M., Bracke, K. R., Dickson, R. P., Hansbro, P. M., Krauss-Etschmann, S., Smits, H. H., Stassen, F. R. M., & Bartel, S. (2020). Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. European Respiratory Journal, 55(6). https://doi.org/10.1183/13993003.02320-2019
  9. 2019
  10. Wojcik-Pszczola, K., Chlon-Rzepa, G., Jankowska, A., Ellen, E., Swierczek, A., Pociecha, K., Koczurkiewicz, P., Piska, K., Gawedzka, A., Wyska, E., Knapik-Czajka, M., Pekala, E., & Gosens, R. (2019). Novel phosphodiesterases inhibitors from the group of purine-2,6-dione derivatives as potent modulators of airway smooth muscle cell remodelling. European Journal of Pharmacology, 865, [172779]. https://doi.org/10.1016/j.ejphar.2019.172779
  11. AIRFLOW-2 Trial Study Group, Slebos, D-J., Shah, P. L., Herth, F. J., Pison, C., Schumann, C., Hübner, R-H., Bonta, P. I., Kessler, R., Gesierich, W., Darwiche, K., Lamprecht, B., Perez, T., Skowasch, D., Deslee, G., Marceau, A., Sciurba, F. C., Gosens, R., Hartman, J. E., ... Valipour, A. (2019). Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe COPD (AIRFLOW): A Multicenter Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine, 200(12), 1477-1486. https://doi.org/10.1164/rccm.201903-0624OC
Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 32600